By the end of 2018, Bayer HealthCare will stop selling Essure—a contraceptive device that has caused severe injuries and complications for thousands of women. Marketed as a permanent, nonsurgical method of contraception, Essure has caused debilitating adverse side-effects including chronic pain, pregnancy, miscarriage, perforation of the uterus or other organs, and even death. From 2002, when Essure was approved by the FDA, to the end of 2017, the agency had received at least 27,000 reports of adverse events relating to Essure.
A class action generally involves one or two named plaintiffs who seek to represent a class of several individuals not named in the complaint. In contrast, a mass tort occurs when several plaintiffs, each of which have separate and distinct cases, are joined together in a single action.
You are an individual and so is your claim! If, after reviewing your unique situation with our attorneys, you decide to move forward with a lawsuit, please know that your case will remain your own individual case, as opposed to a class action. Our lawyers will file a suit based on your particular circumstances and any damages awarded will be based solely on your experience.
Severe complications have been linked to permanent birth control Essure, prompting lawsuits and increased safety concerns for women implanted
with the device.
Recent research shows that
Zofran - taken by pregnant women for morning sickness can increases the risk of cleft palate or congenital
Widespread reports of injury are emerging from patients who have taken the blood-thinning drug Xarelto. The anticoagulant has been
linked to internal...
Taxotere Chemotherapy Drug
Taxotere is a chemotherapy drug approved in the treatment of breast cancer along with other forms of cancers, though it carries a risk of permanent hair loss.
Zimmer Biomet Shoulder Implant
Recalled Zimmer Biomet shoulder implant may fracture, potentially leading to
Hernia mesh products have been associated with side-effects such as infection, severe abdominal pain, and hernia reoccurrence.